Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
As of March 2025 75.00% is owned by Indian Promoters and 25.00% by Public. Top five Promoters holding highest number of shares of Bafna Pharmaceutica...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding Intimation for MPS Compliance .more...
Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations ...more...
Certificate under Regulation74(5) of SEBI (DP) Regulations 2018 for Quarter ended March 31 2025more...
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Resignation of Independent director.more...
Intimation for resignation of Mr. Krishna Yeachuri as an Independent Director of the Company with effect from closure of business hours on M...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.more...
We hereby inform that Mr. Krishna Yeachuri has tendered his resignation as an Independent Director of the Company with effect from close of ...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Krishna Yeachuri as an Independent Director of the company w.e.f....more...
We hereby enclose the Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations 2015 received from M/s. SRJR ...more...
Bafna Pharmaceuticals Limited has informed the Exchange regarding Disclosure under Regulation 7(2) of SEBI (PIT) Regulations 2015 .more...
Notice of the proposed offer for sale (\OFS\) of equity shares of face value of Rs. 10 each fully paid-up (\Equity Shares\) of Bafna Pharmac...more...
SRJR Lifesciences LLP has informed the Exchange about an announcement with respect to offer for sale through Stock Exchange Mechanism for sale upto 3...more...
BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Windowmore...
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regula...more...
Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication in connection with Unaudited Financial Results o...more...
Integrated Filing (Financial) for the Quarter and Nine Months ended December 31 2024.more...
Integrated Filing (Financial) for the Quarter and Nine Months ended December 31 204more...
The company reported standalone net profit during the quarter stood at Rs 0.95 crore compared to net loss of Rs 2.94 crore in the previous year quart...more...
Unaudited Financial Results for the Quarter and Nine Months ended 31/12/2024more...
Enter Stock
BOARD MEETINGS Company Name : Aadhar Housing Fin Date : 06-05-2025